This stimulation can help prevent upper airway obstruction. This treatment option may be an alternative option for people who find it uncomfortable to sleep with devices on their face. Yet it also ...

"With this study, we aimed to explore the relationship between the immune system, schizophrenia and treatment resistance. Our goal was to identify immune cell changes that could potentially be ...

Acadia Pharmaceuticals CEO Catherine Owen Adams stated: “This application underscores our continued dedication to the Rett community, and our commitment to making a meaningful impact for people living ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now found a commercialization partner for both the U.S. and Asian markets.

Upper airway stimulation therapy is a new sleep apnea treatment. It’s also called hypoglossus nerve stimulation. Your doctor will put three small devices in your chest during surgery to track ...

The breakthrough has been described as an "exciting step" in the fight against treatment resistance in such patients. The drug, NXP800, aims at the heat shock factor 1 (HSF1) pathway, which is a ...